12.16.25 -- Why Your MVP And Its Evolution Matters To Manufacturing

Explore how utilizing technologies like AI and digital twinning can inform decision-making at the R&D stage and how to optimize the delivery of the final drug product to patients with greener logistics.

Dive into case studies that demonstrate the performance of a bispecific pairing technology that drives correct heavy-light chain pairing rates in IgG-like bispecifics to >95%.

The linker is key to an ADC's success, influencing stability and targeted drug release. Learn about the evolution of linker chemistry, from cleavable mechanisms to site-specific conjugation.

Conducted alongside Palacky University's Faculty of Medicine and supported by the Technology Agency of the Czech Republic, this project focused on translating research into a viable medicinal product.

Discover how a CDMO with extensive experience in protein variant characterization, CQA analytics, and patient-centric product development can ensure the safety and efficacy of your biotherapeutic.

Learn how knowledge of microbial processes and process characterization understanding can be used to design targeted BLA programs while managing risks.

Technology can transform the entire biopharma production process chain. Using integrated process models, machine learning, and genetic algorithms has made production faster and more efficient.

Explore eight essential reasons why leading BioPharma companies trust this GxP partner to support compliance and operational success in regulated environments.

Computational Fluid Dynamics simulation is essential for robust biologics tech transfer. See how this predictive tool optimizes critical scale-up processes, reducing risk and expediting time to market.

The process associated with the manufacture of CAR-T cell therapies presents challenges that immensely impact patient accessibility to these treatments. Reducing manufacturing complexity is key.